Selection and clearance of entecavir-resistant HBV strains in lamivudine-resistant hepatitis B patient treated with entecavir:A case report

Ri-cheng MAO,Ji-ming ZHANG,You-kuan YIN,Yan-li QIN,Wan-qin ZHANG,Qin-bo ZHANG,Xiang-hui WU,Xin-hua WENG
DOI: https://doi.org/10.3969/j.issn.1008-1704.2007.03.004
2007-01-01
Abstract:Objective Backgrounds & Aims:Entecavir-resistant strains were selected in a lamivudine-resistant hepatitis B patient during entecavir monotherapy.The entecavir-resistant strains afterward disappeared spontaneously and HBeAg seroconversion occurred while entecavir therapy continued.The evolution of the viral quasispecies of the patient was analyzed.Methods A series of blood samples and clinical data of the patient were collected.PCR-Restriction Fragment Length Polymorphism(RFLP)、clonal analysis and DNA sequencing methods were used to examine the evolution of HBV populations in serum samples.Results The patient had pre-existing lamivudine-resistant mutants(rtL180M+rtM204V)before starting entecavir therapy,and these mutants were once inhibited after entecavir therapy.Lamivudine-resistant mutants became predominant HBV population again during extended entecavir therapy over time.The entecavir-resistant strain(rtL180M+rtM204V+rtT184L)was selected 128 weeks with entecavir monotherapy,accompanied by ALT flares and virological rebounds.However,when the patient continued to receive entecavir monotherapy,the entecavir-resistant strains disappeared,with undetectable levels of HBV-DNA by nested PCR 、 ALT normalization and HBeAg seroconversion.Conclusion Entecavir is effective for the treatment of lamivudine-resistant chronic HBV patients,but increased risk of entecavir-resistance is associated with long-term entecavir monotherapy.However,continued entecavir therapy after the selection of entecavir-resistant strain may remain effective,and even HBeAg seroconversion and clearance of HBV DNA may occur.If is possible that pre-existing lamivudine-resistant mutants before the selection of entecavir-resistant strain is prerequisite for the clearance of hepatitis B virus.
What problem does this paper attempt to address?